Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tubular effects of dapagliflozin assessed by 1H NMR spectroscopy
2015-003873-13Phase 4Completed
- Sponsor
- IEDM
- Start
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of dapagliflozin and chlorthalidone in type 2 diabetes mellitus (T2DM) and hypertension (HTN), sponsored by IEDM. Started Oct 2015; status: completed.
02
Drugs
dapagliflozinchlorthalidone
03
Conditions
type 2 diabetes mellitus (T2DM)hypertension (HTN)
Beyond the preview
Go deeper on 2015-003873-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-003873-13.